Biomaterials for Precision Cancer Medicine | Agenda Bookshop Skip to content
Selected Colleen Hoover Books at €9.99c | In-store & Online
Selected Colleen Hoover Books at €9.99c | In-store & Online
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Masoud Mozafari
B01=Saeid Kargozar
Category1=Non-Fiction
Category=MJCL
Category=MQW
Category=TCB
Category=TGM
COP=United States
Delivery_Pre-order
Language_English
PA=Not yet available
Price_€100 and above
PS=Forthcoming
softlaunch

Biomaterials for Precision Cancer Medicine

English

Biomaterials for Precision Cancer Medicine bridges the gap between materials science and medicine, providing insights into novel biomaterial-based treatments for cancer. The book describes the various smart biomaterial-based treatments available, reviewing how they can be designed to target specific tumor types, adapt to changes in the cell microenvironment and offer smart, personalized therapy for different cancer variants, especially those which are drug-resistant. The book provides a materials-focused look at precision cancer medicine, and is thus useful to materials scientists, biomedical engineers, and biomedical scientists including cancer and genetic specialists with an interest in alternative cancer therapies. See more
Current price €279.29
Original price €293.99
Save 5%
Age Group_Uncategorizedautomatic-updateB01=Masoud MozafariB01=Saeid KargozarCategory1=Non-FictionCategory=MJCLCategory=MQWCategory=TCBCategory=TGMCOP=United StatesDelivery_Pre-orderLanguage_EnglishPA=Not yet availablePrice_€100 and abovePS=Forthcomingsoftlaunch

Will deliver when available. Publication date 15 Oct 2024

Product Details
  • Dimensions: 152 x 229mm
  • Publication Date: 15 Oct 2024
  • Publisher: Elsevier Science Publishing Co Inc
  • Publication City/Country: United States
  • Language: English
  • ISBN13: 9780323856614

About

Saeid Kargozar is a Fellow of the University of Texas Southwestern Medical Center (UTSW) USA. He was previously a Senior Assistant Professor of Tissue Engineering in the Department of Anatomy and Cell Biology at Mashhad University of Medical Sciences in Iran. He received his M.S. in Medical Biotechnology in 2012 and his Ph.D. in Tissue Engineering in 2016 both from Tehran University of Medical Sciences Iran. His current research interests include biocompatible materials and tissue engineering with special focus on bioactive glasses and the decellularized extracellular matrix (ECM). He is an active member of the American Ceramic Society and has published more than 118 peer-reviewed publications. According to a recent scientometric study published in PLOS Biology in 2021 he is listed amongst the top 2% of cited scientists in the world. Dr. Masoud Mozafari is a Fellow at Lunenfeld Tanenbaum Research Institute Mount Sinai Health Hospital University of Toronto. He was previously Assistant Professor and Director of the Bioengineering Lab at the Nanotechnology and Advanced Materials Department Materials and Energy Research Center Cellular and Molecular Research Center and Department of Tissue Engineering and Regenerative Medicine of the Iran University of Medical Sciences (IUMS) Tehran Iran. Dr. Mozafaris research interests range across biomaterials nanotechnology and tissue engineering and he is known for the development of strategies for the treatment of damaged tissues and organs and controlling biological substances for targeted delivery into the human body. Dr. Mozafari has received several awards including the Khwarizmi Award and the Julia Polak European Doctorate Award for outstanding translational research contributions to the field of biomaterials. He has also received the WIPO Medal for Inventors from The World Intellectual Property Organization (WIPO) in recognition of his contributions to economic and technological development. Dr. Mozafari is currently working on the editorial board of several journals.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept